PACS Group (PACS) Expected to Post Earnings on Tuesday

PACS Group (NYSE:PACS) is expected to be issuing its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect the company to announce earnings of $0.5370 per share and revenue of $1.4139 billion for the quarter. Parties can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 11:30 AM ET.

PACS Group (NYSE:PACS) last announced its earnings results on Monday, May 11th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. PACS Group had a net margin of 4.49% and a return on equity of 26.47%. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.36 billion. On average, analysts expect PACS Group to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

PACS Group Trading Down 0.2%

NYSE PACS opened at $45.94 on Monday. PACS Group has a 12 month low of $7.50 and a 12 month high of $48.00. The company has a debt-to-equity ratio of 0.27, a current ratio of 0.99 and a quick ratio of 0.99. The company has a 50-day moving average of $40.94 and a 200-day moving average of $37.61. The company has a market cap of $7.27 billion, a P/E ratio of 29.45, a P/E/G ratio of 1.38 and a beta of -0.08.

Insider Transactions at PACS Group

In other PACS Group news, CAO Michelle Renee Lewis sold 15,000 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $40.01, for a total transaction of $600,150.00. Following the transaction, the chief accounting officer owned 370,338 shares of the company’s stock, valued at approximately $14,817,223.38. This trade represents a 3.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Mark Hancock sold 153,254 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $36.34, for a total transaction of $5,569,250.36. Following the transaction, the insider owned 54,449,343 shares in the company, valued at $1,978,689,124.62. This represents a 0.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 796,524 shares of company stock valued at $31,611,396. 70.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On PACS Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PACS. Alyeska Investment Group L.P. raised its stake in shares of PACS Group by 159.5% in the 4th quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock valued at $86,378,000 after acquiring an additional 1,382,984 shares in the last quarter. Marshall Wace LLP grew its position in PACS Group by 348.6% in the 3rd quarter. Marshall Wace LLP now owns 1,010,906 shares of the company’s stock worth $13,880,000 after purchasing an additional 785,537 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in shares of PACS Group by 120.4% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,129,612 shares of the company’s stock worth $14,595,000 after purchasing an additional 617,124 shares during the period. Balyasny Asset Management L.P. lifted its stake in shares of PACS Group by 67.3% in the third quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company’s stock valued at $18,621,000 after buying an additional 545,348 shares during the period. Finally, Nuveen LLC grew its position in PACS Group by 284.7% during the fourth quarter. Nuveen LLC now owns 579,239 shares of the company’s stock worth $22,237,000 after buying an additional 428,672 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Oppenheimer upped their price target on PACS Group from $42.00 to $48.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. UBS Group increased their price objective on shares of PACS Group from $50.00 to $57.00 and gave the company a “buy” rating in a research report on Wednesday, July 8th. Truist Financial upped their price objective on shares of PACS Group from $50.00 to $52.00 and gave the company a “buy” rating in a research report on Monday, May 18th. Weiss Ratings upgraded PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, July 8th. Finally, Zacks Research lowered PACS Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $50.60.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.